Table of Contents

1 Study Coverage

• 1.1 Epistaxis Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Epistaxis Market Size Growth Rate by Product
  • 1.4.2 Vasoconstrictors
  • 1.4.3 Anesthetics
  • 1.4.4 Antibiotic Ointments
  • 1.4.5 Cauterizing Agents
• 1.5 Market by End User
  • 1.5.1 Global Epistaxis Market Size Growth Rate by End User
  • 1.5.2 Pediatric
  • 1.5.3 Adult
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Epistaxis Market Size
  • 2.1.1 Global Epistaxis Revenue 2014-2025
  • 2.1.2 Global Epistaxis Sales 2014-2025
• 2.2 Epistaxis Growth Rate by Regions
  • 2.2.1 Global Epistaxis Sales by Regions
  • 2.2.2 Global Epistaxis Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Epistaxis Sales by Manufacturers
  • 3.1.1 Epistaxis Sales by Manufacturers
  • 3.1.2 Epistaxis Sales Market Share by Manufacturers
  • 3.1.3 Global Epistaxis Market Concentration Ratio (CR5 and HHI)
• 3.2 Epistaxis Revenue by Manufacturers
  • 3.2.1 Epistaxis Revenue by Manufacturers (2014-2019)
  • 3.2.2 Epistaxis Revenue Share by Manufacturers (2014-2019)
• 3.3 Epistaxis Price by Manufacturers
• 3.4 Epistaxis Manufacturing Base Distribution, Product Types
  • 3.4.1 Epistaxis Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Epistaxis Product Type
  • 3.4.3 Date of International Manufacturers Enter into Epistaxis Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Epistaxis Sales by Product
• 4.2 Global Epistaxis Revenue by Product
• 4.3 Epistaxis Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Epistaxis Breakdown Data by End User

6 North America

• 6.1 North America Epistaxis by Countries
  • 6.1.1 North America Epistaxis Sales by Countries
  • 6.1.2 North America Epistaxis Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Epistaxis by Product
• 6.3 North America Epistaxis by End User

7 Europe

• 7.1 Europe Epistaxis by Countries
  • 7.1.1 Europe Epistaxis Sales by Countries
  • 7.1.2 Europe Epistaxis Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Epistaxis by Product
• 7.3 Europe Epistaxis by End User

8 Asia Pacific

• 8.1 Asia Pacific Epistaxis by Countries
  • 8.1.1 Asia Pacific Epistaxis Sales by Countries
  • 8.1.2 Asia Pacific Epistaxis Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Epistaxis by Product
• 8.3 Asia Pacific Epistaxis by End User

9 Central & South America

• 9.1 Central & South America Epistaxis by Countries
  • 9.1.1 Central & South America Epistaxis Sales by Countries
  • 9.1.2 Central & South America Epistaxis Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Epistaxis by Product
• 9.3 Central & South America Epistaxis by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Epistaxis by Countries
  • 10.1.1 Middle East and Africa Epistaxis Sales by Countries
  • 10.1.2 Middle East and Africa Epistaxis Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Epistaxis by Product
• 10.3 Middle East and Africa Epistaxis by End User

11 Company Profiles

• 11.1 Smith & Nephew
  • 11.1.1 Smith & Nephew Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Smith & Nephew Epistaxis Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Smith & Nephew Epistaxis Products Offered
  • 11.1.5 Smith & Nephew Recent Development
• 11.2 Medline
  • 11.2.1 Medline Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Medline Epistaxis Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Medline Epistaxis Products Offered
  • 11.2.5 Medline Recent Development
• 11.3 Bristol-Myers Squibb Pharma Company
  • 11.3.1 Bristol-Myers Squibb Pharma Company Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Bristol-Myers Squibb Pharma Company Epistaxis Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Bristol-Myers Squibb Pharma Company Epistaxis Products Offered
  • 11.3.5 Bristol-Myers Squibb Pharma Company Recent Development
• 11.4 Ciron Drugs
  • 11.4.1 Ciron Drugs Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Ciron Drugs Epistaxis Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Ciron Drugs Epistaxis Products Offered
  • 11.4.5 Ciron Drugs Recent Development
• 11.5 King Pharmaceuticals, Inc
  • 11.5.1 King Pharmaceuticals, Inc Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 King Pharmaceuticals, Inc Epistaxis Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 King Pharmaceuticals, Inc Epistaxis Products Offered
  • 11.5.5 King Pharmaceuticals, Inc Recent Development

12 Future Forecast

• 12.1 Epistaxis Market Forecast by Regions
  • 12.1.1 Global Epistaxis Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Epistaxis Revenue Forecast by Regions 2019-2025
• 12.2 Epistaxis Market Forecast by Product
  • 12.2.1 Global Epistaxis Sales Forecast by Product 2019-2025
  • 12.2.2 Global Epistaxis Revenue Forecast by Product 2019-2025
• 12.3 Epistaxis Market Forecast by End User
• 12.4 North America Epistaxis Forecast
• 12.5 Europe Epistaxis Forecast
• 12.6 Asia Pacific Epistaxis Forecast
• 12.7 Central & South America Epistaxis Forecast
• 12.8 Middle East and Africa Epistaxis Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Epistaxis Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details

Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive and could not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter, as more of the upper respiratory infections occur during this season.
The global Epistaxis market is valued at 140 million US$ in 2018 and will reach 210 million US$ by the end of 2025, growing at a CAGR of 5.7% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Epistaxis market based on company, product type, end user and key regions.

This report studies the global market size of Epistaxis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Epistaxis in these regions.
This research report categorizes the global Epistaxis market by top players/brands, region, type and end user. This report also studies the global Epistaxis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Smith & Nephew
Medline
Bristol-Myers Squibb Pharma Company
Ciron Drugs
King Pharmaceuticals, Inc

Market size by Product
Vasoconstrictors
Anesthetics
Antibiotic Ointments
Cauterizing Agents
Market size by End User
Pediatric
Adult

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Epistaxis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Epistaxis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Epistaxis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Epistaxis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Epistaxis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Epistaxis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.